Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Pharmacokinetics and biodistribution study of paclitaxel liposome in Sprague-Dawley rats and Beagle dogs by liquid chromatography-tandem mass spectrometry.

Wang X, Song L, Li N, Qiu Z, Zhou S, Li C, Zhao J, Song H, Chen X.

Drug Res (Stuttg). 2013 Nov;63(11):603-6. doi: 10.1055/s-0033-1349126. Epub 2013 Jul 10.

PMID:
23842945
2.

Liquid chromatography/tandem triple-quadrupole mass spectrometry for determination of paclitaxel in rat tissues.

Tong X, Zhou J, Tan Y.

Rapid Commun Mass Spectrom. 2006;20(12):1905-12.

PMID:
16715470
3.

Liquid chromatography-tandem mass spectrometry for the determination of paclitaxel in rat plasma after intravenous administration of poly(L-glutamic acid)-alanine-paclitaxel conjugate.

Zhang SQ, Song YN, He XH, Zhong BH, Zhang ZQ.

J Pharm Biomed Anal. 2010 Apr 6;51(5):1169-74. doi: 10.1016/j.jpba.2009.11.030. Epub 2009 Dec 4.

PMID:
20036092
4.

Pharmacokinetics of paclitaxel-containing liposomes in rats.

Fetterly GJ, Straubinger RM.

AAPS PharmSci. 2003 Nov 21;5(4):E32.

5.

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.

Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, Kim DD.

Int J Pharm. 2007 Jun 29;338(1-2):317-26. Epub 2007 Feb 13.

PMID:
17368984
6.
8.
9.

Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.

Han LM, Guo J, Zhang LJ, Wang QS, Fang XL.

Acta Pharmacol Sin. 2006 Jun;27(6):747-53.

10.
11.

Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?

Shord SS, Camp JR.

Biopharm Drug Dispos. 2006 May;27(4):191-6.

PMID:
16566060
12.

Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.

Liu J, Kraut EH, Balcerzak S, Grever M, D'Ambrosio S, Chan KK.

Cancer Chemother Pharmacol. 2002 Dec;50(6):445-53. Epub 2002 Oct 16.

PMID:
12451470
13.

Bio-distribution and pharmacokinetics of nobiliside A-loaded liposome following intravenous administration in rats.

Xiong Y, Chen J, Guo D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jul 1;962:132-40. doi: 10.1016/j.jchromb.2014.03.039. Epub 2014 May 5.

PMID:
24911548
14.

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.

Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L.

J Control Release. 2000 Jan 3;63(1-2):19-30.

PMID:
10640577
15.

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.

Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ.

Cancer Chemother Pharmacol. 2009 May;63(6):1049-63. doi: 10.1007/s00280-008-0827-2. Epub 2008 Sep 13.

PMID:
18791718
16.

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.

Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.

Biomaterials. 2008 Mar;29(9):1233-41.

PMID:
18093646
17.

Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogs.

Zhong J, Mao W, Shi R, Jiang P, Wang Q, Zhu R, Wang T, Ma Y.

Cancer Chemother Pharmacol. 2014 Mar;73(3):459-66. doi: 10.1007/s00280-013-2369-5. Epub 2013 Dec 22.

PMID:
24362508
18.

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules.

Peltier S, Oger JM, Lagarce F, Couet W, Benoît JP.

Pharm Res. 2006 Jun;23(6):1243-50. Epub 2006 May 25.

PMID:
16715372
19.

Pharmacokinetics of huperzine A in dogs following single intravenous and oral administrations.

Chu D, Liu W, Li Y, Li P, Gu J, Liu K.

Planta Med. 2006 May;72(6):552-5.

PMID:
16773540
Items per page

Supplemental Content

Write to the Help Desk